Prognostic Value of Procalcitonin and C-Reactive Protein in 1608 Critically Ill Patients with Severe Influenza Pneumonia.
No Thumbnail Available
Identifiers
Date
2021-03-26
Authors
Carbonell, Raquel
Moreno, Gerard
Martín-Loeches, Ignacio
Gomez-Bertomeu, Frederic
Sarvisé, Carolina
Gómez, Josep
Bodí, María
Díaz, Emili
Papiol, Elisabeth
Trefler, Sandra
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Background: Procalcitonin (PCT) and C-Reactive protein (CRP) are well-established sepsis biomarkers. The association of baseline PCT levels and mortality in pneumonia remains unclear, and we still do not know whether biomarkers levels could be related to the causative microorganism (GPC, GNB). The objective of this study is to address these issues. Methods: a retrospective observational cohort study was conducted in 184 Spanish ICUs (2009-2018). Results: 1608 patients with severe influenza pneumonia with PCT and CRP available levels on admission were included, 1186 with primary viral pneumonia (PVP) and 422 with bacterial Co-infection (BC). Those with BC presented higher PCT levels (4.25 [0.6-19.5] versus 0.6 [0.2-2.3]ng/mL) and CRP (36.7 [20.23-118] versus 28.05 [13.3-109]mg/dL) as compared to PVP (p
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
C-Reactive protein, Gram negative bacilli, Gram-positive cocci, mortality, pneumonia, procalcitonin